Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Expert Rev Ophthalmol. 2020 Mar 12;15(2):111–118. doi: 10.1080/17469899.2020.1739522

Figure. 3.

Figure. 3.

Examples of the CAR line-blot testing for 3 different sera from patient suspected of cancer-associated retinopathy, showing patterns individual for those antibodies. The serum samples were tested at the Ocular Immunology Laboratory in Portland, OR.